Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA3 | P07451 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA6 | P23280 | 2/20 | 0.53 |
| ▸ | CA5A | P35218 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.53 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18342693 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL17102164 | 0.97 | CHRM2 (0.52) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL18342675 | 0.97 | — | — | |
| SCHEMBL14738852 | 0.86 | ALDH1A1 (0.38) | CHRM2DNM1TSHRALDH1A1 | |
| SCHEMBL31240836 | 0.76 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL1273916 | 0.76 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL720253 | 0.76 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL27297758 | 0.76 | CHRM2 (0.58) | CHRM2DNM1CA12CA1CA2 | |
| SCHEMBL8945918 | 0.73 | — | — | |
| SCHEMBL817873 | 0.73 | CHRM2 (0.55) | CHRM2DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 127 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113402482-B | Bismaleic acid alcohol ester heat stabilizer with oxygen bridge molecular structure and preparation method thereof | 江南大学 | 2024-06-25 | — | — | CN | claimed |
| EP-2650282-B1 | Process for producing substituted methylamine compound and triazine derivative | NIPPON SODA CO (JP) | 2017-06-07 | — | — | EP | claimed |
| EP-2650283-B1 | Process for producing substituted methylamine compound and triazine derivative | NIPPON SODA CO (JP) | 2017-06-07 | — | — | EP | claimed |
| US-9302274-B2 | Collector compositions and methods of using the same | CYTEC TECHNOLOGY CORP. (US) | 2016-04-05 | — | — | US | claimed |
| US-9302272-B2 | Froth flotation processes | CYTEC TECHNOLOGY CORP. (US) | 2016-04-05 | — | — | US | claimed |
| US-9000156-B2 | Process for producing substituted methylamine compound and triazine derivative | NIPPON SODA CO., LTD. (JP) | 2015-04-07 | — | — | US | claimed |
| EP-2141149-B1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | NIPPON SODA CO (JP) | 2014-10-29 | — | — | EP | claimed |
| EP-2768618-A2 | FROTH FLOTATION PROCESSES | Cytec Technology Corp. (US) | 2014-08-27 | — | — | EP | claimed |
| EP-2768616-A2 | COLLECTOR COMPOSITIONS AND METHODS OF USING THE SAME | Cytec Technology Corp. (US) | 2014-08-27 | — | — | EP | claimed |
| EP-2650283-A1 | Process for producing substituted methylamine compound and triazine derivative | NIPPON SODA CO., LTD. (JP) | 2013-10-16 | — | — | EP | claimed |
| WO-2013059259-A2 | FROTH FLOTATION PROCESSES | CYTEC TECHNOLOGY CORP. (US) | 2013-04-25 | — | — | WO | claimed |
| US-20130092603-A1 | Collector Compositions and Methods of Using the Same | CYTEC TECHNOLOGY CORP. (US) | 2013-04-18 | — | — | US | claimed |
| US-20130092604-A1 | Froth Flotation Processes | CYTEC TECHNOLOGY CORP. (US) | 2013-04-18 | — | — | US | claimed |
| US-20100121054-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | NIPPON SODA CO., LTD. (JP) | 2010-05-13 | — | — | US | claimed |
| EP-2141149-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | Nippon Soda Co., Ltd. (JP) | 2010-01-06 | — | — | EP | claimed |
| US-5204482-A | Ethylenediamine monoamide heteroaryl derivatives | HOFFMAN-LAROCHE INC. (US) | 1993-04-20 | — | — | US | claimed |
| EP-0330218-A2 | Inhibitors of lysyl oxidase | MERRELL DOW PHARMACEUTICALS INC. (US) | 1989-08-30 | — | — | EP | claimed |
| EP-0067105-B1 | ALLYL AMINE MAO INHIBITORS | MERRELL DOW FRANCE ET CIE (FR) | 1987-09-23 | — | — | EP | claimed |
| EP-0125684-B1 | 2-ALKYLTHIO-1-AMINOALKYL-2-PYRROLINE-3-CARBONITRILES, PROCESS FOR THEIR PREPARATION AND MEDICINES WITH ANTI-THROMBOTIC EFFECTS CONTAINING THEM | GÖDECKE AKTIENGESELLSCHAFT (DE) | 1987-07-08 | — | — | EP | claimed |
| EP-0067105-A2 | Allyl amine MAO inhibitors | MERRELL DOW FRANCE ET CIE (FR) | 1982-12-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100121054-A1 | PROCESS FOR PRODUCING SUBSTITUTED METHYLAMINE COMPOUND AND TRIAZINE DERIVATIVE | INMT, BHMT2, HNMT | CHRM2 107/4885DNM1 4200/4885CA12 2622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.